Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Environment
Hurvitz And Wilchek Win
Recipients are honored for contributions of major significance to chemistry
February 28, 2011
| A version of this story appeared in
Volume 89, Issue 9
The Israel Chemical Society awarded its most prestigious honor, the Israel Chemical Society Medal, to scientists Eli Hurvitz and Meir Wilchek during a ceremony before the Knesset, the Israeli legislative branch, on Jan. 4.
Hurvitz, former chief executive officer of Teva Pharmaceutical Industries, led the company for 35 years, transforming it from a small, unknown pharmaceutical business into a world leader in generic pharmaceuticals. Today, Teva is Israel’s largest company, employing roughly 40,000 people around the world.
Wilchek, Marc R. Gutwirth Chair of Molecular Biology at the Weizmann Institute of Science, is credited with the development of affinity chromatography, which is used to separate and purify proteins.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X